Article
Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Article
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Article
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Article
In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.
Article
In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture.
We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.